FAST, NCT02611973: Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia |
|
|
| Recruiting | 3 | 2250 | Europe | Aspirin therapy interruption, Usual treatment by aspirin 100 mg/d in the active comparator arm, No interruption of aspirin in the Observational arm, Hydroxyurea treatment (HU) | Assistance Publique - Hôpitaux de Paris | MPN, Essential Thrombocythemia | 11/19 | 11/22 | | |
| Recruiting | 2/3 | 116 | Europe | Eltrombopag, Experimental arm, Placebo (for Eltrombopag), control | B. Höchsmann | Anemia, Aplastic | 09/22 | 09/23 | | |